ClinConnect ClinConnect Logo
Search / Trial NCT06159517

Heart Lung Machine Registry

Launched by MAQUET CARDIOPULMONARY GMBH · Nov 28, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Heart Lung Machine Hl 40 Temperature Probes Tpo D Hlm L1.8 Adult Tpo D Hlm L1.8 Pediatric

ClinConnect Summary

**Summary of the Heart Lung Machine Registry Trial**

The Heart Lung Machine Registry is a clinical trial that is looking at the safety and effectiveness of specific medical devices used during heart, lung, and vascular surgeries. These devices, called the Heart Lung Machine HL 40 and Temperature Probes, help manage blood flow and temperature while patients are undergoing surgery that requires support for their heart and lungs. The trial is currently recruiting participants of all ages, as long as they are undergoing these types of surgeries and have signed the necessary consent forms.

To be eligible for this study, participants must be connected to the Heart Lung Machine during their surgery. However, pregnant individuals and those who are also taking part in other clinical trials involving new drugs or devices cannot join this study. If you or a family member qualifies and decides to participate, you can expect to contribute to valuable research that aims to improve surgical outcomes for future patients. Your involvement will help healthcare providers understand how well these devices work and ensure they are safe for use.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Signed Patient Informed Consent (including emergency approach)
  • All patients who are connected to extracorporeal circulation using the index devices.
  • Exclusion Criteria:
  • Pregnancy
  • Current participation or planned participation in a concurrent drug or interventional medical device study

About Maquet Cardiopulmonary Gmbh

Maquet Cardiopulmonary GmbH is a leading global provider of advanced medical technologies and solutions specializing in cardiopulmonary care. With a commitment to enhancing patient outcomes, the company focuses on the development and manufacturing of innovative equipment and devices for cardiac surgery, extracorporeal circulation, and respiratory support. Leveraging cutting-edge research and a strong dedication to quality, Maquet Cardiopulmonary GmbH collaborates with healthcare professionals to deliver effective, safe, and reliable products that meet the evolving needs of the medical community. Their extensive portfolio and expertise in clinical trials underscore their role as a key player in advancing treatment options for patients worldwide.

Locations

Madrid, , Spain

Rome, , Italy

Bilbao, , Spain

Patients applied

0 patients applied

Trial Officials

Alejandro Crespo de Hubsch, Dr.

Principal Investigator

Hospital Universitario de Cruces

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported